Inicio » 2017 » Volume 3 - Number 1 » Alterations in Nutritional Status and Body Composition in COPD Patients
Joaquim Gea 1, 2, 3, Cristina Estirado 4, Esther Barreiro 5, 6, 7, 8
1 Department of Respiratory Medicine, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain; 2 Department of MELIS, Universitat Pompeu Fabra, Barcelona, Spain; 3 Área de Enfermedades Respiratorias, CIBER, ISCIII, Barcelona, Spain; 4 Respiratory Medicine Department, Hospital del Mar IMIM, DCEXS, Universitat Pompeu Fabra, CIBERES, ISCIII, Barcelona, Spain; 5 Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Hospital del Mar Research Institute, Barcelona, Spain; 6 Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain; 7 Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Barcelona, Spain; 8 Department of Pulmonology, Hospital del Mar, Passeig Marítim de la Barceloneta, Barcelona, Spain
Joaquim Gea, Cristina Estirado, Esther Barreiro
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Cristina Estirado, Email not available
This review focuses on nutritional abnormalities, one of the most prominent extra pulmonary manifestations occurring in chronic obstructive pulmonary disease (COPD). Diagnosis is usually made by either anthropometry or determination of body composition. Deficiencies in nutritional status, such as body weight and muscle mass loss, are the result of an interaction of several factors, including the imbalance between energy supply and requirements, tobacco, low physical activity, and systemic inflammation. These factors essentially determine the predominance of protein breakdown over synthesis. The loss of body weight and lean mass leads to muscle dysfunction and exercise limitation, also having a negative impact on exacerbations and mortality. Therapies include changes in lifestyle and nutritional supplements. Anabolic drugs may be administered in some cases. Obesity is also very prevalent in COPD patients, being associated with cardiovascular and metabolic comorbidities. Although, paradoxically, moderate obesity appears to reduce mortality, healthy lifestyle habits are recommended to avoid morbid obesity.